VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CERT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CERTCertara, Inc.
$8.83$1.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCERTBalance Sheet

Certara, Inc. (CERT) Balance Sheet

8Y historyFree accessUpdated daily

Total debt spiked to $291.8M in 2026Q2 from $11.4M in 2025Q4, lifting D/E to 0.30, while goodwill of $718.1M (51% of assets) raises impairment risk.

Income StatementBalance SheetCash FlowRatios

CERT Balance Sheet

Annual statement

CERT Balance Sheet

Certara, Inc. (CERT) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Total Current Assets312.19M315.12M310.85M340.2M342.25M274.73M346.58M87.52M68.93M
Cash & Short-Term Investments184.14M189.39M179.18M234.95M236.59M185.8M271.38M29.26M11.68M
Cash Only184.14M189.39M179.18M234.95M236.59M185.8M271.38M29.26M11.68M
Short-Term Investments000000000
Accounts Receivable113.9M116.27M119.08M93.26M88.81M78.31M64.8M52.36M49.88M
Days Sales Outstanding97.46101.32112.8596.0696.5799.997.1291.65111.21
Inventory000000005.53M
Days Inventory Outstanding--------28.43
Other Current Assets2.76M1.13M4.27M5.63M8.47M1.65M3.03M2.14M3.32M
Total Non-Current Assets1.09B1.24B1.26B1.22B1.23B1.24B922.82M949.55M982.56M
Property, Plant & Equipment10.63M13.79M16.01M12.27M16.83M15.57M3.87M4.62M5.4M
Fixed Asset Turnover31.60x30.37x24.06x28.87x19.95x18.38x62.90x45.10x30.31x
Goodwill718.13M773.31M757.04M716.33M717.74M703.37M518.59M515M514.27M
Intangible Assets345.21M447.48M485.21M487.04M486.78M511.82M396.44M428M459.62M
Long-Term Investments000000001.16M
Other Non-Current Assets2.54M1.64M2.03M3.05M5.62M2.17M1.16M1.1M1.26M
Total Assets1.4B1.56B1.58B1.56B1.57B1.51B1.27B1.04B1.05B
Asset Turnover0.27x0.27x0.24x0.23x0.21x0.19x0.19x0.20x0.16x
Asset Growth %-14.85%-1.18%0.77%-0.62%4.05%19.09%22.4%-1.37%-
Total Current Liabilities122.4M153.38M146.09M130.02M103.16M92.22M75.34M63M65.45M
Accounts Payable2.72M3.43M3.5M5.17M7.53M7.46M6.39M4.92M4.91M
Days Payables Outstanding7.137.768.2713.3820.7424.3923.1622.525.22
Short-Term Debt2.96M2.96M3M3.02M3.02M3.02M4.68M4.21M3.15M
Deferred Revenue (Current)294.26M75.41M77.83M60.68M52.21M45.5M30.66M26.24M37.52M
Other Current Liabilities3.16M71.58M53.08M49.51M31.01M26.95M29.45M8.35M12.58M
Current Ratio2.55x2.05x2.13x2.62x3.32x2.98x4.60x1.39x1.05x
Quick Ratio2.55x2.05x2.13x2.62x3.32x2.98x4.60x1.39x0.97x
Cash Conversion Cycle90.33-------114.42
Total Non-Current Liabilities310.88M340.4M370.36M386.28M390.1M377.66M371.92M482.02M493.27M
Long-Term Debt288.88M8.44M292.43M288.22M289.99M291.75M294.1M397.12M404.8M
Capital Lease Obligations16.75M011.17M6.96M10.13M8.28M318K048K
Deferred Tax Liabilities114.07M34.37M40.42M50.83M67.35M76.1M75.89M82.16M85.67M
Other Non-Current Liabilities10.36M297.6M25.3M39.21M19.81M01.07M1.6M0
Total Liabilities433.28M493.79M516.45M516.3M493.26M469.88M447.27M545.02M558.72M
Total Debt291.84M11.4M311.9M302.57M308.13M308.38M299.37M401.38M408.28M
Net Debt107.7M-177.99M132.71M67.62M71.55M122.58M27.99M372.12M396.6M
Debt / Equity0.30x0.01x0.29x0.29x0.29x0.30x0.36x0.82x0.83x
Debt / EBITDA4.94x0.15x4.70x19.78x3.63x5.25x16.33x6.56x12.62x
Net Debt / EBITDA1.82x-2.29x2.00x4.42x0.84x2.09x1.53x6.08x12.26x
Interest Coverage0.81x1.39x0.20x-1.41x2.06x0.80x-0.98x0.67x-0.17x
Total Equity966.51M1.06B1.06B1.05B1.08B1.04B822.13M492.05M492.77M
Equity Growth %-14.45%0.39%1.13%-3.04%3.63%26.73%67.08%-0.15%-
Book Value per Share6.266.636.606.596.786.955.373.133.72
Total Shareholders' Equity966.51M1.06B1.06B1.05B1.08B1.04B822.13M492.05M492.77M
Common Stock1.67M1.64M1.62M1.6M1.6M1.6M1.53M1.32M1.32M
Retained Earnings-193.91M-129.88M-128.28M-116.23M-60.87M-75.6M-62.34M-12.94M-14.43M
Treasury Stock-127.96M-66.66M-18.18M-9.4M-3M-38K000
Accumulated OCI9.06M2.04M-13.42M-7.59M-8.23M-3.93M-1.59M-5.5M-1.65M
Minority Interest000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityWeak
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

EPS miss and margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Contraction Signals Caution

Total assets declined from $1.6B in 2025Q4 to $1.4B in 2026Q2, while cash fell to $184.1M, per reported figures, indicating a shrinking balance sheet amid operational headwinds.

The sequential decline in total assets, from $1.6B to $1.4B, is driven by a reduction in cash and a $52.7M decrease in goodwill, likely reflecting an impairment or divestiture. This contraction, coupled with a rise in total liabilities to $433.3M, suggests the company is consuming resources rather than building them. The trend may indicate a strategic repositioning, but investors should monitor whether asset shrinkage continues, as it could signal deteriorating business quality.

Leverage Spike Masks Underlying Stability

Total debt jumped to $291.8M in 2026Q2 from $11.4M in 2025Q4, lifting D/E to 0.30, per financial statements, though the increase appears tied to refinancing or acquisition activity.

The dramatic increase in total debt, from $11.4M to $291.8M, is a significant shift, but the D/E ratio of 0.30 remains moderate compared to peers like IQV (2.44). The debt likely stems from a strategic refinancing or funding for acquisitions, given the company's history of M&A. However, the elevated debt level, combined with negative retained earnings, suggests that leverage is being used to support growth initiatives, though the associated interest expense could pressure margins if cash flows falter.

Goodwill Dominance Raises Impairment Risk

Goodwill of $718.1M represents 51% of total assets as of 2026Q2, per reported data, highlighting the asset-heavy nature of the balance sheet from past acquisitions.

The asset mix is heavily skewed toward goodwill and intangibles, which together account for the majority of total assets, while PPE is minimal at $10.6M. This indicates an asset-light operational model but a balance sheet laden with acquisition-related intangibles. The recent decline in goodwill from $773.3M to $718.1M suggests a possible impairment, which could recur if the company's market value or cash-generating ability deteriorates. Investors should scrutinize the recoverability of these assets, as further write-downs could erode equity.

Retained Deficit Deepens Despite Buybacks

Retained earnings worsened to -$193.9M in 2026Q2 from -$129.9M in 2025Q4, per reported figures, even as the company repurchased shares, indicating cash outflows exceeding earnings.

The expanding retained deficit, from -$129.9M to -$193.9M, reflects cumulative losses that are not being offset by profits. Despite this, the company has been active in share repurchases, totaling $100M over the last three quarters per cash flow data, which may be aimed at offsetting dilution from stock-based compensation. However, this capital allocation strategy appears to be consuming cash that could otherwise be used to reduce debt or fund operations, potentially straining equity quality if losses persist.

Liquidity Buffer Thins but Remains Adequate

Current ratio fell to 2.55 in 2026Q2 from 2.05 in 2025Q4, per balance sheet data, while cash dropped to $184.1M, still providing a cushion against near-term obligations.

The current ratio of 2.55 indicates that current assets cover current liabilities more than twice over, which is a healthy liquidity position. However, the decline from 2.05 in 2025Q4 (note: actually increased from 2.05 to 2.55) suggests a slight improvement, but cash has decreased from $189.4M to $184.1M. Given the company's operating cash flow of $10M in 2026Q2, the cash runway appears sufficient for the near term, but the thin margin of safety warrants monitoring if cash burn accelerates.

Goodwill Impairment Could Distort Equity

With goodwill at $718.1M, a 10% impairment would reduce equity by over 7%, per reported figures, potentially turning the balance sheet from healthy to strained.

The most non-obvious risk is the substantial goodwill on the balance sheet, which is vulnerable to impairment if the company's market value or cash-generating ability declines. Given the recent EPS miss and revenue deceleration, the likelihood of an impairment may be higher than the market anticipates. A write-down would directly reduce equity, which currently stands at $966.5M, and could also signal that past acquisitions have not delivered expected synergies. Investors should monitor the company's market capitalization relative to book value, as a sustained decline could trigger an impairment test.

CERT — Frequently Asked Questions

Quick answers to the most common questions about buying CERT stock.

What are the total assets of Certara, Inc. (CERT)?

As of 2025, Certara, Inc. (CERT) had total assets of $1.56B including $315.1M in current assets.

How much debt does Certara, Inc. (CERT) have?

Certara, Inc. (CERT) carries total debt of $11.4M, offset by $189.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Certara, Inc.?

Certara, Inc. (CERT) has total shareholders' equity (book value) of $1.06B ($6.63 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Certara, Inc.'s current ratio and liquidity?

Certara, Inc. (CERT) reported a current ratio of 2.05x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.